aleglitazar: Clinical Trials

6 trials of aleglitazar, newest first

ClinicalTrials Daily · Areas · Conditions · Drugs · Sponsors ·

6 completed. 6 Phase 2.

By phase and status

Phase	Trials	Status
Phase 2	6	Completed 6

Follow aleglitazar: new trials by email Literature Review of aleglitazar trials Research Report on aleglitazar

Trials (filtered) newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
A Study of The Effect of Aleglitazar on Insulin Sensitivity in Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled With Metformin aleglitazar, metformin, placebo - Diabetes Mellitus Type 2	Phase 2	Completed	Hoffmann-La Roche	57	2012-12-01	2016-11-02
A Study to Evaluate the Effect of Aleglitazar on Cardiac Energetics and Function in Patients With Type 2 Diabetes Mellitus and no History of Coronary Artery Disease aleglitazar, placebo - Diabetes Mellitus Type 2	Phase 2	Completed	Hoffmann-La Roche	18	2012-10-01	2016-11-02
A Study of Aleglitazar in Type 2 Diabetes Patients With Moderate Renal Impairment aleglitazar, pioglitazone - Diabetes Mellitus Type 2	Phase 2	Completed	Hoffmann-La Roche	302	2010-05-01	2016-11-02
A Comparison of the Effects of Aleglitazar and Actos on Renal Function on Patients With Type 2 Diabetes. Actos, aleglitazar - Diabetes Mellitus Type 2	Phase 2	Completed	Hoffmann-La Roche	176	2007-06-01	2016-08-01
A Comparative Study of Aleglitazar and Actos in Patients With Type 2 Diabetes Mellitus and New York Heart Association (NYHA) Class II Heart Failure. Actos, aleglitazar - Diabetes Mellitus Type 2	Phase 2	Completed	Hoffmann-La Roche	14	2007-05-01	2016-08-05
A Study of Aleglitazar in Patients With Type 2 Diabetes Actos, Placebo, aleglitazar - Diabetes Mellitus Type 2	Phase 2	Completed	Hoffmann-La Roche	332	2006-11-01	2016-11-02

Conditions studied

Sponsors

Countries

Results publications

NIH funding